The actual lytic mechanism at the conclusion of human lymphocyte-mediated natural cytotoxicity has not been described, but it is usually assumed that a mediator is transferred from the effector cell to the target cell. We have recently made three observations that may provide insight into this event: (1) human natural cytotoxicity can be inhibited by mannose-6-phosphate (Man-6-P), which is a known recognition marker for some human lysosomal enzymes; (2) there is a receptor for Man-6-P on the surface of some target cells of natural cytotoxicity; and (3) amine inhibitors of lysosomal receptor recycling cause inhibition of natural cytotoxicity if either of the two elements (effector cell or target cell) are pretreated with these agents. A working hypothesis has been formulated that suggests that, subsequent to effector cell-target cell contact and programming for lysis, a glycoprotein mediator is expressed from the effector cell to the outside where it is bound to, and internalized by, the target cell by virtue of a Man-6-P recognition marker. The internalized mediator may be passed through the target cell lysosome, and it is released into the cytoplasm in a toxic form. It is intended to test this hypothesis and to extend this observation. The temporal relationship of this carbohydrate inhibition to the events of natural cytotoxicity will be explored in detail. Murine cytotoxicity against the YACl target cell line and its two sublines YAC 19 (NK sensitive) and YAC 28 (NK resistant) will be utilized in studies to isolate soluble mediator of cytotoxicity. YAC 28 has been shown to form conjugates with NK cells but appears to be resistant to the lytic consequences. YAC 28 is also relatively resistant to a conjugate of gelonin (a plant toxin with no means of entry into the cell) and pentamannose-6-phosphate (a mannan from Hansenula holstii), which suggests that this cell line is deficient in internalizable surface receptors for Man-6-P. It is intended to use this target cell line as a model in which the target cell can potentially bind to the effector cell and initiate programming for lysis but in which the target cells are also unable to bind the lytic moiety that is subsequently secreted from the effector cell. This provides an ideal environment in which to isolate and characterize partially this lytic moiety. (LB)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA033589-03
Application #
3171410
Study Section
Experimental Immunology Study Section (EI)
Project Start
1983-12-01
Project End
1987-06-30
Budget Start
1985-12-01
Budget End
1987-06-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Stewart, S J; Prpic, V; Johns, J A et al. (1989) Bacterial toxins affect early events of T lymphocyte activation. J Clin Invest 83:234-42
Duke, S S; King, L S; Jones, M R et al. (1989) Human recombinant interleukin 2-activated sheep lymphocytes lyse sheep pulmonary microvascular endothelial cells. Cell Immunol 122:188-99
Fraker, L D; Halter, S A; Forbes, J T (1986) Effects of orally administered retinol on natural killer cell activity in wild type BALB/c and congenitally athymic BALB/c mice. Cancer Immunol Immunother 21:114-8